Metabolite Profiling Stratifies Pancreatic Ductal Adenocarcinomas

Total Page:16

File Type:pdf, Size:1020Kb

Metabolite Profiling Stratifies Pancreatic Ductal Adenocarcinomas Metabolite profiling stratifies pancreatic ductal PNAS PLUS adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors Anneleen Daemena, David Petersonb,1, Nisebita Sahub,1, Ron McCordb,1, Xiangnan Duc, Bonnie Liuc, Katarzyna Kowanetzb, Rebecca Hongc, John Moffatd, Min Gaoc, Aaron Boudreaub, Rana Mroueb, Laura Corsonc, Thomas O’Brienc, Jing Qingc, Deepak Sampathc, Mark Merchantc, Robert Yauchb, Gerard Manninga, Jeffrey Settlemanb, Georgia Hatzivassiliouc, and Marie Evangelistab,2 aBioinformatics and Computational Biology, Genentech, South San Francisco, CA 94080; bDiscovery Oncology, Genentech, South San Francisco, CA 94080; cTranslational Oncology, Genentech, South San Francisco, CA 94080; and dBiochemical Pharmacology, Genentech, South San Francisco, CA 94080 Edited by Ronald A. DePinho, University of Texas M.D. Anderson Cancer Center, Houston, TX, and approved June 22, 2015 (received for review January 29, 2015) Although targeting cancer metabolism is a promising therapeutic therapeutic targets (9, 10). Just as tumors vary greatly in genomic strategy, clinical success will depend on an accurate diagnostic alterations that impact signaling and regulatory pathways, meta- identification of tumor subtypes with specific metabolic require- bolic transformation is also heterogeneous and dependent on tissue ments. Through broad metabolite profiling, we successfully identified type, proliferation rate, and isoenzyme use (9, 11). In addition, the three highly distinct metabolic subtypes in pancreatic ductal adeno- observed differences in the dependence on and utilization of the carcinoma (PDAC). One subtype was defined by reduced proliferative major nutrients—glutamine and glucose—are linked to oncogenic capacity, whereas the other two subtypes (glycolytic and lipogenic) signaling and the genomic features of a cancer cell (12). showed distinct metabolite levels associated with glycolysis, lipo- Large-scale pharmacogenomic screening is a powerful method genesis, and redox pathways, confirmed at the transcriptional level. for identifying biomarkers of drug response and can accelerate The glycolytic and lipogenic subtypes showed striking differences in the search for new cancer therapies (13, 14). In this study, we glucose and glutamine utilization, as well as mitochondrial function, used broad baseline metabolite profiling in cell line models of CELL BIOLOGY and corresponded to differences in cell sensitivity to inhibitors of pancreatic ductal adenocarcinoma (PDAC), a disease context glycolysis, glutamine metabolism, lipid synthesis, and redox balance. previously associated with altered metabolism (15–18), to iden- In PDAC clinical samples, the lipogenic subtype associated with the tify metabolic subtypes within PDAC and predict their sensitivity epithelial (classical) subtype, whereas the glycolytic subtype to various metabolic inhibitors. strongly associated with the mesenchymal (QM-PDA) subtype, suggesting functional relevance in disease progression. Pharmaco- Results ∼ genomic screening of an additional 200 non-PDAC cell lines vali- Baseline Metabolite Profiling Identifies Three Metabolic Subtypes in dated the association between mesenchymal status and metabolic PDAC. We examined cell lines derived from naturally occurring drug response in other tumor indications. Our findings highlight the tumors because they recapitulate many aspects of the tissue type utility of broad metabolite profiling to predict sensitivity of tumors to a variety of metabolic inhibitors. Significance metabolite profiling | metabolic subtypes in PDAC | glycolysis | lipid synthesis | biomarkers for metabolic inhibitors Targeting cancer metabolism requires personalized diagnostics for clinical success. Pancreatic ductal adenocarcinoma (PDAC) is characterized by metabolism addiction. To identify metabolic de- etabolic reprogramming during tumorigenesis is an essential pendencies within PDAC, we conducted broad metabolite profiling Mprocess in nearly all cancer cells. Tumors share a common and identified three subtypes that showed distinct metabolite phenotype of uncontrolled cell proliferation and must efficiently profiles associated with glycolysis, lipogenesis, and redox path- generate the energy and macromolecules required for cellular ways. Importantly, these profiles significantly correlated with growth. The first example of metabolic reprogramming was dis- enriched sensitivity to a variety of metabolic inhibitors including coveredmorethan80yagobyOttoWarburg:tumorcellscanshift inhibitors targeting glycolysis, glutaminolysis, lipogenesis, and re- from oxidative to fermentative metabolism in the course of onco- dox balance. In primary PDAC tumor samples, the lipid subtype genesis (1). More recently, there has been a resurgence of interest was strongly associated with an epithelial phenotype, whereas the in targeting cancer metabolism (2–4) because it may not only be ef- glycolytic subtype was strongly associated with a mesenchymal fective in inhibiting tumor growth, but may also provide a therapeutic phenotype, suggesting functional relevance in disease progression. window (5, 6). For example, inactivation of lactate dehydrogenase-A Our findings will provide valuable predictive utility for a number of (LDHA), an enzyme that catalyzes the final step of aerobic gly- metabolic inhibitors currently undergoing phase I testing. colysis, thereby reducing pyruvate to lactate, decreases tumorigenesis and induces regression of established tumors in mouse models of Author contributions: A.D., G.H., and M.E. designed research; A.D., D.P., K.K., R.Y., G.M., J.S., KRAS G.H., and M.E. performed research; A.D., D.P., N.S., R. McCord, X.D., B.L., K.K., R.H., J.M., lung cancer driven by oncogenic or epidermal growth factor M.G., A.B., R. Mroue, L.C., T.O., J.Q., and M.E. contributed new reagents/analytic tools; receptor (EGFR) while minimally affecting normal cell function A.D., D.P., N.S., R. McCord, X.D., B.L., K.K., R.H., J.M., M.G., A.B., R. Mroue, L.C., T.O., J.Q., (7). The finding that cancers have altered metabolism has prompted D.S., M.M., G.H., and M.E. analyzed data; and A.D. and M.E. wrote the paper. substantial investigation, both preclinically and in clinical trials, of The authors declare no conflict of interest. several metabolically targeted agents, including those that elevate This article is a PNAS Direct Submission. reactive oxygen species (ROS) or block glycolysis, lipid synthesis, Freely available online through the PNAS open access option. mitochondrial function, and glutamine synthesis pathways (8). 1D.P., R. McCord, and N.S. contributed equally to this work. The identification of distinct metabolic reprogramming events 2To whom correspondence should be addressed. Email: [email protected]. or metabolic subtypes in cancer may inform patient selection for This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. investigational metabolic inhibitors and in the selection of new 1073/pnas.1501605112/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1501605112 PNAS Early Edition | 1of8 Downloaded by guest on October 2, 2021 and genomic context of cancer (13, 14, 19, 20). Levels of 256 with the lipogenic lines (P < 0.05; Fig. 1E and Fig. S1K). In con- metabolites were quantified in 38 pancreatic cancer cell lines (five trast, cell lines within the lipogenic subtype were enriched for ex- biological replicates per cell line) in logarithmic growth phase using pression of lipogenesis genes involved in cholesterol and de novo media with physiological glucose and glutamine concentrations lipid synthesis including 7-dehydrocholesterol reductase (DHCR7), (Datasets S1–S3). We applied nonnegative matrix factorization stearoyl-CoA desaturase (SCD), and fatty acid synthase (FASN) (NMF) (21), a recently established approach for consensus clus- (adjusted P < 0.1; Fig. 1 E and F, Fig. S1 H and L,andDataset tering (22–24), to 153 metabolites with reproducible variation, S6). Thus, PDAC-derived cell lines can be clustered by their allowing the capture of the strongest signal of metabolic de- metabolite profiles and these differences appear to be determined pendency (SI Materials and Methods). This analysis revealed three in part by differences in gene expression. stable and reproducible subtypes with adequate data coherence (Fig. S1 A and B). The metabolite profiles of the cell lines ordered Glycolytic and Lipogenic Subtypes Use Glucose and Glutamine in a by subtype are shown in Fig. 1A for metabolites with distinct in- Different Manner. The metabolic and transcriptional profiles sug- tensities in at least one subtype compared with the other two gested that these two subtypes may differ in their use of glucose subtypes (F test, P < 0.05). These three subtypes provided a useful and glutamine, the most abundant carbon sources available to and interpretable basis for further analysis. cancer cells. We predicted that the lipogenic subtype would preferentially use glucose for the tricarboxylic acid (TCA) cycle Metabolic Characterization Reveals a Slow Proliferating, Glycolytic, and lipid synthesis, whereas the glycolytic subtype would use glu- and Lipogenic Subtype. The metabolite intensities within each cose more for aerobic glycolysis, and consequently, use more glu- subtypewerethenmappedtoknown,previouslyestablished tamine for TCA anaplerosis. 13C metabolic mass isotopomer metabolic ontologies (Dataset S1 and SI Materials and Methods) distribution analysis (MIDA) using either [U-13C5]glutamine or (25). One
Recommended publications
  • Dynamical Reduction of Metabolic Networks by Singular Perturbation Theory : Application to Microalgae Claudia Lopez Zazueta
    Dynamical reduction of metabolic networks by singular perturbation theory : application to microalgae Claudia Lopez Zazueta To cite this version: Claudia Lopez Zazueta. Dynamical reduction of metabolic networks by singular perturbation theory : application to microalgae. Signal and Image processing. COMUE Université Côte d’Azur (2015 - 2019), 2018. English. NNT : 2018AZUR4108. tel-02411569 HAL Id: tel-02411569 https://tel.archives-ouvertes.fr/tel-02411569 Submitted on 15 Dec 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THÈSE DE DOCTORAT Réduction dynamique de réseaux métaboliques par la théorie des perturbations singulières : Application aux microalgues Claudia LÓPEZ ZAZUETA Institut National de Recherche en Informatique et en Automatique (Inria) Équipe-Projet BIOCORE Présentée en vue de l’obtention Devant le jury, composé de : du grade de docteur en Sciences Alexander Bockmayr, Professeur, Freie d’Université Côte d’Azur Universität Berlin Mention : Automatique, Traitement du Diego Oyarzún, Lecturer in Computational Signal et des Images Biology,
    [Show full text]
  • Metabolic Modelling of Wine-Making : a State of the Art
    METABOLIC MODELLING OF WINE-MAKING : A STATE OF THE ART Robert David and Denis Dochain1, Alain Vande Wouwer2, Jean-Roch Mouret and Jean-Marie Sablayrolles3 1Université Catholique de Louvain, Belgium, 2Faculté Polytechnique de Mons, Belgium, 3INRA - Montpellier SupAgro, France Corresponding author: Robert David, Center for Systems Engineering and Applied Mechanics (CESAME) Université Catholique de Louvain, Avenue Georges Lemaître 4, 1348 Louvain-la-Neuve, Belgium, ÐÓÙÚÒº Abstract. The yeast Saccharomyces cerevisiae is one of the most studied micro-organism, due to its numerous applications (beer, wine, bakery, bioethanol). This good knowledge of the species was notably considered in modelling approaches where the intracellular behaviour is taken into account. Among them Metabolic Flux Analysis and Elementary Flux Modes are tools of interest to develop a mathematical model of the fermentation process including some characteristic flavour compounds. The present paper describes what has been done in the restrained field of wine-making/fermentation conditions, and underlines the potential of such approaches. 1 Introduction As in most food processes, there is a need to increase the development of efficient control tools in order to im- ºÓÖ prove the quality of food products. This is one of the issue of the EC CAFE project ( ). In the context of wine-making, an a priori attractive path may be to consider microbiological knowledge about the production of the important organoleptic properties of the wine in order to develop new appropriate control approaches that can help to guarantee the production of wine of defined quality. In the nineties, as technical progresses in biotechnology were decisive, Saccharomyces cerevisiae has become the first eukaryotic organism1 whose genome was fully sequenced, denoting the interest for its better understanding.
    [Show full text]
  • Profiling Cellular Processes in Adipose Tissue During Weight Loss Using Time Series Gene Expression
    G C A T T A C G G C A T genes Article Profiling Cellular Processes in Adipose Tissue during Weight Loss Using Time Series Gene Expression Samar H. K. Tareen 1,* , Michiel E. Adriaens 1,* , Ilja C. W. Arts 1,2, Theo M. de Kok 1,3, Roel G. Vink 4, Nadia J. T. Roumans 4, Marleen A. van Baak 4, Edwin C. M. Mariman 4, Chris T. Evelo 1,5,* and Martina Kutmon 1,5,* 1 Maastricht Centre for Systems Biology (MaCSBio), Maastricht University, 6211ER Maastricht, The Netherlands; [email protected] (I.C.W.A.); [email protected] (T.M.d.K.) 2 Department of Epidemiology, CARIM School for Cardiovascular Diseases, Maastricht University, 6211ER Maastricht, The Netherlands 3 Department of Toxicogenomics, GROW School of Oncology and Developmental Biology, Maastricht University, 6211ER Maastricht, The Netherlands 4 Department of Human Biology, NUTRIM Research School, Maastricht University, 6211ER Maastricht, The Netherlands; [email protected] (R.G.V.); [email protected] (N.J.T.R.); [email protected] (M.A.v.B.); [email protected] (E.C.M.M.) 5 Department of Bioinformatics—BiGCaT, NUTRIM Research School, Maastricht University, 6211ER Maastricht, The Netherlands * Correspondence: [email protected] (S.H.K.T.); [email protected] (M.E.A.); [email protected] (C.T.E.); [email protected] (M.K.) Received: 28 September 2018; Accepted: 22 October 2018; Published: 29 October 2018 Abstract: Obesity is a global epidemic identified as a major risk factor for multiple chronic diseases and, consequently, diet-induced weight loss is used to counter obesity.
    [Show full text]
  • Metabolic Flux Analysis—Linking Isotope Labeling and Metabolic Fluxes
    H OH metabolites OH Review Metabolic Flux Analysis—Linking Isotope Labeling and Metabolic Fluxes Yujue Wang 1,2, Fredric E. Wondisford 1, Chi Song 3, Teng Zhang 4 and Xiaoyang Su 1,2,* 1 Department of Medicine, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA; [email protected] (Y.W.); [email protected] (F.E.W.) 2 Metabolomics Shared Resource, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA 3 Division of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH 43210, USA; [email protected] 4 Department of Mathematics, University of Central Florida, Orlando, FL 32816, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-732-235-5447 Received: 14 September 2020; Accepted: 4 November 2020; Published: 6 November 2020 Abstract: Metabolic flux analysis (MFA) is an increasingly important tool to study metabolism quantitatively. Unlike the concentrations of metabolites, the fluxes, which are the rates at which intracellular metabolites interconvert, are not directly measurable. MFA uses stable isotope labeled tracers to reveal information related to the fluxes. The conceptual idea of MFA is that in tracer experiments the isotope labeling patterns of intracellular metabolites are determined by the fluxes, therefore by measuring the labeling patterns we can infer the fluxes in the network. In this review, we will discuss the basic concept of MFA using a simplified upper glycolysis network as an example. We will show how the fluxes are reflected in the isotope labeling patterns. The central idea we wish to deliver is that under metabolic and isotopic steady-state the labeling pattern of a metabolite is the flux-weighted average of the substrates’ labeling patterns.
    [Show full text]
  • A Critical View of Metabolic Network Adaptations
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by DSpace at VU HFSP Journal PERSPECTIVE A critical view of metabolic network adaptations Balázs Papp,1 Bas Teusink,2,3,4,5 and Richard A. Notebaart2,4 1Institute of Biochemistry, Biological Research Center, H-6701 Szeged, Hungary 2Center for Molecular and Biomolecular Informatics ͑NCMLS͒, Radboud University Nijmegen Medical Center, 6500GL Nijmegen, The Netherlands 3TI Food and Nutrition, Wageningen / NIZO food research, 6710BA Ede, The Netherlands 4Kluyver Center for Genomics of Industrial Fermentation, 2628 BC Delft, The Netherlands 5Present address: The Center for Integrative Bioinformatics ͑IBIVU͒, Faculty of Earth and Life Science, Vrije University Amsterdam, 1081HV Amsterdam, The Netherlands ͑Received 18 August 2008; accepted 20 October 2008; published online 3 December 2008) There has been considerable recent interest in deciphering the adaptive properties underlying the structure and function of metabolic networks. Various features of metabolic networks such as the global topology, distribution of fluxes, and mutational robustness, have been proposed to have adaptive significance and hence reflect design principles. However, whether evolutionary processes alternative to direct selection on the trait under investigation also play a role is often ignored and the selection pressures maintaining a given metabolic trait often remain speculative. Some systems-level traits might simply arise as by-products of selection on other traits or even through random genetic drift. Here, we ask which systems-level aspects of metabolism are likely to have adaptive utility and which could be better explained as by-products of other evolutionary forces. We conclude that the global topological characteristics of metabolic networks and their mutational robustness are unlikely to be directly shaped by natural selection.
    [Show full text]
  • Remodeling Adipose Tissue Through in Silico Modulation of Fat Storage For
    Chénard et al. BMC Systems Biology (2017) 11:60 DOI 10.1186/s12918-017-0438-9 RESEARCHARTICLE Open Access Remodeling adipose tissue through in silico modulation of fat storage for the prevention of type 2 diabetes Thierry Chénard2, Frédéric Guénard3, Marie-Claude Vohl3,4, André Carpentier5, André Tchernof4,6 and Rafael J. Najmanovich1* Abstract Background: Type 2 diabetes is one of the leading non-infectious diseases worldwide and closely relates to excess adipose tissue accumulation as seen in obesity. Specifically, hypertrophic expansion of adipose tissues is related to increased cardiometabolic risk leading to type 2 diabetes. Studying mechanisms underlying adipocyte hypertrophy could lead to the identification of potential targets for the treatment of these conditions. Results: We present iTC1390adip, a highly curated metabolic network of the human adipocyte presenting various improvements over the previously published iAdipocytes1809. iTC1390adip contains 1390 genes, 4519 reactions and 3664 metabolites. We validated the network obtaining 92.6% accuracy by comparing experimental gene essentiality in various cell lines to our predictions of biomass production. Using flux balance analysis under various test conditions, we predict the effect of gene deletion on both lipid droplet and biomass production, resulting in the identification of 27 genes that could reduce adipocyte hypertrophy. We also used expression data from visceral and subcutaneous adipose tissues to compare the effect of single gene deletions between adipocytes from each
    [Show full text]
  • Modelling Cell Metabolism: a Review on Constraint-Based Steady-State and Kinetic Approaches
    processes Review Modelling Cell Metabolism: A Review on Constraint-Based Steady-State and Kinetic Approaches Mohammadreza Yasemi and Mario Jolicoeur * Research Laboratory in Applied Metabolic Engineering, Department of Chemical Engineering, École Polytechnique de Montréal, P.O. Box 6079, Centre-ville Station, Montréal, QC H3C 3A7, Canada; [email protected] * Correspondence: [email protected] Abstract: Studying cell metabolism serves a plethora of objectives such as the enhancement of bio- process performance, and advancement in the understanding of cell biology, of drug target discovery, and in metabolic therapy. Remarkable successes in these fields emerged from heuristics approaches, for instance, with the introduction of effective strategies for genetic modifications, drug develop- ments and optimization of bioprocess management. However, heuristics approaches have showed significant shortcomings, such as to describe regulation of metabolic pathways and to extrapolate experimental conditions. In the specific case of bioprocess management, such shortcomings limit their capacity to increase product quality, while maintaining desirable productivity and reproducibility levels. For instance, since heuristics approaches are not capable of prediction of the cellular functions under varying experimental conditions, they may lead to sub-optimal processes. Also, such ap- proaches used for bioprocess control often fail in regulating a process under unexpected variations of external conditions. Therefore, methodologies inspired by the systematic mathematical formulation of cell metabolism have been used to address such drawbacks and achieve robust reproducible results. Mathematical modelling approaches are effective for both the characterization of the cell Citation: Yasemi, M.; Jolicoeur, M. physiology, and the estimation of metabolic pathways utilization, thus allowing to characterize Modelling Cell Metabolism: A a cell population metabolic behavior.
    [Show full text]
  • Differential Effects of Insulin Signaling on Individual Carbon Fluxes for Fatty Acid Synthesis in Brown Adipocytes
    Differential effects of insulin signaling on individual carbon fluxes for fatty acid synthesis in brown adipocytes Hyuntae Yoo*, Maciek Antoniewicz†, Joanne K. Kelleher†, and Gregory Stephanopoulos† Departments of Chemistry* and Chemical Engineering†, Massachusetts Institute of Technology, Cambridge, MA 02139, U.S.A. events of type II diabetes [1]. Therefore, understanding the Abstract— Considering the major role of insulin signaling detailed mechanism of regulation for fat synthesis and its on fatty acid synthesis via stimulation of lipogenic enzymes, relationship with insulin signaling may provide insights differential effects of insulin signaling on individual carbon into the pathogenesis of the two diseases and help fluxes for fatty acid synthesis have been investigated by preventing them. comparing the individual lipogenic fluxes in WT and IRS-1 knockout (IRS-1 KO) brown adipocytes. Results from Insulin signaling has long been associated with elevating experiments on WT and IRS-1 KO cells incubated with [5- overall lipogenic activity through increased activity of 13C] glutamine were consistent with the existence of reductive lipogenic enzymes [2]. Evidences have been accumulated carboxylation pathway. Analysis of isotopomer distribution that many of these enzymes are stimulated directly by of nine metabolites related to the lipogenic routes from insulin signaling via insulin response element at their glucose and glutamine in IRS-1 KO cells using [U-13C] transcription level or indirectly by insulin signaling to glutamine as compared to that in WT cells indicated that flux through reductive carboxylation pathway was diminished transcription factors [3]. However, studies on stimulation while flux through conventional TCA cycle was stimulated of lipogenic enzymes’ activity by insulin signaling have due to absence of insulin signaling in IRS-1 KO cells.
    [Show full text]
  • Metabolic Network Construction Based on the Genome of The
    San Jose State University SJSU ScholarWorks Master's Theses Master's Theses and Graduate Research Fall 2013 Metabolic Network Construction Based on the Genome of the Marine Diatom Thalassiosira Pseudonana and the Analysis of Genome-wide Transcriptome Data to Investigate Triacylglyceride Accumulation Karen Parker San Jose State University Follow this and additional works at: https://scholarworks.sjsu.edu/etd_theses Recommended Citation Parker, Karen, "Metabolic Network Construction Based on the Genome of the Marine Diatom Thalassiosira Pseudonana and the Analysis of Genome-wide Transcriptome Data to Investigate Triacylglyceride Accumulation" (2013). Master's Theses. 4400. DOI: https://doi.org/10.31979/etd.mved-nx78 https://scholarworks.sjsu.edu/etd_theses/4400 This Thesis is brought to you for free and open access by the Master's Theses and Graduate Research at SJSU ScholarWorks. It has been accepted for inclusion in Master's Theses by an authorized administrator of SJSU ScholarWorks. For more information, please contact [email protected]. METABOLIC NETWORK CONSTRUCTION BASED ON THE GENOME OF THE MARINE DIATOM THALASSIOSIRA PSEUDONANA AND THE ANALYSIS OF GENOME-WIDE TRANSCRIPTOME DATA TO INVESTIGATE TRIACYLGLYCERIDE ACCUMULATION A Thesis Presented to The Faculty of Moss Landing Marine Labs San José State University In Partial Fulfillment of the Requirements for the Degree Master of Science By Karen R. Parker December 2013 © 2013 Karen R. Parker ALL RIGHTS RESERVED The Designated Thesis Committee Approves the Thesis Titled METABOLIC NETWORK CONSTRUCTION BASED ON THE GENOME OF THE MARINE DIATOM THALASSIOSIRA PSEUDONANA AND THE ANALYSIS OF GENOME-WIDE TRANSCRIPTOME DATA TO INVESTIGATE TRIACYLGLYCERIDE ACCUMULATION By Karen R. Parker APPPROVED FOR MOSS LANDING MARINE LABS SAN JOSÉ STATE UNIVERSITY December 2013 Dr.
    [Show full text]
  • Metabolic Plasticity Meets Gene Regulation COMMENTARY B
    COMMENTARY Metabolic plasticity meets gene regulation COMMENTARY B. Bishal Paudela,b and Vito Quarantaa,b,1 Tumor metabolism has been investigated as an ex- A ploitable avenue for treatment in the last several years. The link between tumor and metabolism traces its origin to a seminal observation by Otto Warburg, almost a century ago, that cancer cells, regardless of oxygen availability, convert most intracellular glucose to lactate—that is, aerobic glycolysis (1). This elevated glycolytic state of cancer cells has been elegantly exploited to detect tumors and their response to drugs by positron emission tomography through the B use of fluorodeoxyglucose (2). Originally, tumor cells were thought to have dysfunctional mitochondria, but accumulating evidence suggests that they utilize gly- colysis, oxidative phosphorylation, or both, depending on context unrelated to the integrity of mitochondria (3). Additionally, cancer cells can switch their metabolic phenotypes during tumor progression and metastasis and/or in response to external perturbations (4). This Fig. 1. Metabolic landscape of normal and cancer cells. (A) Transcriptomics and metabolic plasticity provides both the energy and the metabolomics (end-product metabolites) analyses show the coexistence of necessary intermediates for biosynthetic processes re- three distinct metabolic phenotypes: glycolytic (W), oxidative (O), and high- quired for tumor growth. Recently, this “deregulation high, or hybrid (W/O) states in cancer cells, whereas normal cells exhibit only ” two states. (B) External perturbations lead to metabolic reprogramming in of cellular energetics has been recognized as an emerg- cancer cells. (Left) glycolytic inhibition increases the O and W/O states. (Middle) ing hallmark of cancer (5). OXPHOS inhibition increases the W and W/O states.
    [Show full text]
  • Metabolic Network-Based Stratification of Hepatocellular Carcinoma Reveals Three Distinct Tumor Subtypes
    Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes Gholamreza Bidkhoria,b,1, Rui Benfeitasa,1, Martina Klevstigc,d, Cheng Zhanga, Jens Nielsene, Mathias Uhlena, Jan Borenc,d, and Adil Mardinoglua,b,e,2 aScience for Life Laboratory, KTH Royal Institute of Technology, SE-17121 Stockholm, Sweden; bCentre for Host-Microbiome Interactions, Dental Institute, King’s College London, SE1 9RT London, United Kingdom; cDepartment of Molecular and Clinical Medicine, University of Gothenburg, SE-41345 Gothenburg, Sweden; dThe Wallenberg Laboratory, Sahlgrenska University Hospital, SE-41345 Gothenburg, Sweden; and eDepartment of Biology and Biological Engineering, Chalmers University of Technology, SE-41296 Gothenburg, Sweden Edited by Sang Yup Lee, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea, and approved November 1, 2018 (received for review April 27, 2018) Hepatocellular carcinoma (HCC) is one of the most frequent forms of of markers associated with recurrence and poor prognosis (13–15). liver cancer, and effective treatment methods are limited due to Moreover, genome-scale metabolic models (GEMs), collections tumor heterogeneity. There is a great need for comprehensive of biochemical reactions, and associated enzymes and transporters approaches to stratify HCC patients, gain biological insights into have been successfully used to characterize the metabolism of subtypes, and ultimately identify effective therapeutic targets. We HCC, as well as identify drug targets for HCC patients (11, 16–18). stratified HCC patients and characterized each subtype using tran- For instance, HCC tumors have been stratified based on the uti- scriptomics data, genome-scale metabolic networks and network lization of acetate (11). Analysis of HCC metabolism has also led topology/controllability analysis.
    [Show full text]
  • Function, Detection and Alteration of Acylcarnitine Metabolism in Hepatocellular Carcinoma
    H OH metabolites OH Review Function, Detection and Alteration of Acylcarnitine Metabolism in Hepatocellular Carcinoma Shangfu Li 1,2, Dan Gao 1,2,3,* and Yuyang Jiang 1,4 1 State Key Laboratory of Chemical Oncogenomics, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, China; [email protected] (S.L.); [email protected] (Y.J.) 2 National & Local United Engineering Lab for Personalized Anti-tumour Drugs, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, China 3 Key Laboratory of Metabolomics at Shenzhen, Shenzhen 518055, China 4 School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China * Correspondence: [email protected]; Tel.: +86-755-26036035 Received: 11 January 2019; Accepted: 14 February 2019; Published: 21 February 2019 Abstract: Acylcarnitines play an essential role in regulating the balance of intracellular sugar and lipid metabolism. They serve as carriers to transport activated long-chain fatty acids into mitochondria for β-oxidation as a major source of energy for cell activities. The liver is the most important organ for endogenous carnitine synthesis and metabolism. Hepatocellular carcinoma (HCC), a primary malignancy of the live with poor prognosis, may strongly influence the level of acylcarnitines. In this paper, the function, detection and alteration of acylcarnitine metabolism in HCC were briefly reviewed. An overview was provided to introduce the metabolic roles of acylcarnitines involved in fatty acid β-oxidation. Then different analytical platforms and methodologies were also briefly summarised. The relationship between HCC and acylcarnitine metabolism was described. Many of the studies reported that short, medium and long-chain acylcarnitines were altered in HCC patients.
    [Show full text]